RayzeBio
- Founded: 2020
- Location: San Diego, CA
- Employee range: 50 - 200
- Clinical stage: Clin3
- Therapy area: neuroendocrine tumors
- Drug types: ONC
- Lead product: RYZ101
- Product link: https://rayzebio.com/pipeline/pipeline-overview/
- Funding: $160M D Sep 2022; $108M C Jun 2021; $105M B Dec 2020; $45M A Oct 2020
- Investors: Versant, VenBio, Samsara BioCapital, Viking Global Investors, Sofinnova Investments, Wellington Management, Ally Bridge Group, Sands Capital, Laurion Capital Management, Soleus Capital
rayzebio.com linkedin.com job board
Short description:
Radiopharmaceuticals Therapy for Cancer
Drug notes:
Also Clin1 SCLC; Glypican-3 Clin0 Liver Cancer; 5 add'l RD programs solid tumors
Long description:
Contact us to add description: recruit@workinbiotech.com
Jobs:
Associate Director, Program Management
San Diego, California, Stati Uniti d'America|5 days ago
Manager, Quality Assurance Operations
Indianapolis, Indiana, Stati Uniti d'America|5 days ago
Manager of Supply Chain Operations
إنديانابوليس وضواحيها|11 days ago
Quality Systems Associate/Specialist
إنديانا إنديانابوليس الولايات المتحدة|12 days ago
Director, Scientific Communications and Publicatio...
الولايات المتحدة|15 days ago
Document Control Specialist
Indianapolis, IN|18 days ago
Director, Production
Greater Indianapolis|23 days ago
Manager, Quality Assurance Systems
Indiana, United States|25 days ago
Materials Coordinator
Indianapolis, IN|33 days ago
Logistics Specialist
Indianapolis, IN|33 days ago
© 2024 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com